Despite $3.1 billion in sales, venture investment in biostimulants fell by 86% in 2024. Why? Because consistency and scalability remain unresolved challenges across the value chain.
What’s holding back adoption?
- Rising production and formulation costs
- Performance variability across soils, crops, and climates
- Limited distribution and cold-chain logistics
- Knowledge and technical-support gaps
- Fragmented regulations across markets
Each factor increases risk, cost, or uncertainty — eroding confidence in long-term ROI.
Still, progress is being made. New formulation science, shelf-life technologies, and packaging innovations (like high-barrier multilayers, MAP, or active antimicrobial coatings) are extending product durability and cutting waste.
Longer shelf lives alone can raise profit potential by over 30% through reduced spoilage and better inventory turnover.
When combined with improved field data, predictive agronomy, and precision farming tools, biologics are moving closer to dependable performance— one innovation at a time.
Sustainable input technologies aren’t a passing phase.
They are the future’s foundation— bridging productivity with ecological balance.
🌱 The best is truly yet to come for biologics, biostimulants, and sustainable crop nutrition.
